Pharmacotherapy of disorders in mental retardation

European Child and Adolescent Psychiatry

Volumn 9, Issue SUPPL. 1, 2000, Pages

  Aman, M G ^a   Collier Crespin, A ^a   Lindsay, R L ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Drug research; Mental retardation; Pharmacotherapy; Psychiatric disorder

Indexed keywords

DESMOPRESSIN; IMIPRAMINE; LITHIUM CARBONATE; NALTREXONE;

ANXIETY NEUROSIS; ARTICLE; ATTENTION DEFICIT DISORDER; DEPRESSION; DRUG RESEARCH; ENURESIS; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; MENTAL DEFICIENCY; MENTAL DISEASE; MOTOR DYSFUNCTION; SCHIZOPHRENIA; TIC;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MENTAL RETARDATION; MOVEMENT DISORDERS;

EID: 0033672103     PISSN: 10188827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007870070023     Document Type: Article

References (69)

1. Overview of pharmacotherapy: Current status and future directions
2. Efficacy of psychotropic drugs for reducing self-injurious behavior in the developmental disabilities
3. Stimulant drugs in the developmental disabilities revisited
4. Review of serotonergic agents and perseverative behavior in patients with developmental disabilities
5. Stimulants
6. Stimulants
7. Neuroleptics
8. The psychopharmacology of nocturnal enuresis
9. Placebo, double-blind evaluation of long-term naltrexone treatment effects for adults with mental retardation and self-injury
10. Midazolam for agressivity and violence in three mentally retarded patients
11. Depression and suicide among adolescents and young adults with selective handicapping conditions
12. Self-injurious behaviour in retarded children: Clinical phenomena and biological mechanisms
13. Naltrexone in autistic children: Behavioral symptoms and attentional learning
14. Risperidone for aggression and self-injurious behavior in adults with mental retardation
15. Psychiatric disturbance in mentally handicapped patients
16. Haloperidol in the treatment of children with severe behavior disorders
17. Long-term experience with lithium treatment in childhood: Correlation with clinical diagnosis
18. Ervaringen met psychofarmaca bij zwakzinnige kindern
19. Antiaggressive effects of lithium salts in severe mentally retarded adolescents
20. Issues in the taxonomy of psychopathology in children and adolescents with mental retardation
21. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression
22. Expert consensus guideline series: Treatment of psychiatric and behavioral problems in mental retardation
23. Fenfluramine
24. Rapid cycling affective disorders in the mentally retarded
25. Lithium carbonate in the management of hyperactive aggressive behavior of the mentally retarded
26. Case study of neuroleptic-induced akathisia: Important implications for people with mental retardation
27. 1 hypothesis
28. Pharmacotherapy in mental retardation and autism
29. Risperidone and explosive aggressive autism
30. Pubertal manic depressive psychosis and mental subnormality - A case report
31. Valproic acid for the treatment of children with mental retardation and mood symptomatology
32. Chlordiazepoxide in treatment of children with emotional disturbances
33. The use of psychopharmacological agents in retarded children with behavior disorders
34. Clonidine treatment of Gilles de la Tourette's syndrome
35. Short-cycle manic-depressive psychosis in a mentally handicapped child without family history
36. Clinical and economic aspects of risperidone treatment in adults with mental retardation and behavioral disturbance
37. Diagnosis and pharmacotherapy of schizophrenia in the retarded
38. Desmopessin acetate and nocturnal enuresis: How much do we know?
39. A double-blind trial of long-term lithium therapy in mental defectives
40. Dyskinetic phenomena in children treated with psychotropic medications
41. Patterns of delinquent behavior
42. Buspirone treatment of aggression and anxiety in mentally retarded patients: A multiple baseline, placebo lead-in study
43. A double-blind placebo controlled cross over trial of carbamazepine in overactive severely mentally handicapped patients
44. The psychotropic effects of carbamazepine in nonepileptic patients, with particular reference to problems posed by clinical studies in children with behavioural disorders
45. Der verwendung von trimeprimin in der kinderheikunde
46. Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent patients
47. Epidemiology and psychoactive medication
48. Diagnosis and lithium treatment of affective disorders in the retarded: Five case studies
49. Epidemiology and topographic taxonomy of self-injurious behavior
50. Treatment of bipolar mood disorder in persons with mental retardation
51. The use of clozapine in borderline-intellectual-functioning and mentally retarded schizophrenic patients
52. Opiate blockers
53. Nocturnal enuresis
54. Dopaminergic mechanisms in self-injurious behavior
55. Controlled study of haloperidol, pimozide, and placebo for the treatment of Gilles de la Tourette's syndrome
56. Nortriptyline hydrochloride in the treatment of enuresis in mentally retarded boys
57. The use of valproate in the treatment of mentally retarded persons with typical and atypical bipolar disorders
58. Antidepressant drugs
59. Diagnosis of mental disorders in people with mental retardation
60. Schizophrenia and mental handicap: A historical review, with implications for further research
61. Antidepressant and antimanic drugs
62. Antiepileptics (Anticonvulsants)
63. Valproic acid for dysphoric mania in a mentally retarded adolescent
64. Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. Double-blind placebo-controlled studies